Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Peter Múdrý"'
Autor:
Hana Palova, Anirban Das, Petra Pokorna, Viera Bajciova, Zdenek Pavelka, Marta Jezova, Karol Pal, Jose R. Dimayacyac, Logine Negm, Lucie Stengs, Vanessa Bianchi, Klara Vejmelkova, Kristyna Noskova, Marie Jarosova, Sona Mejstrikova, Peter Mudry, Michal Kyr, Tomas Merta, Pavel Tinka, Klara Drabova, Stefania Aulicka, Robin Jugas, Uri Tabori, Ondrej Slaby, Jaroslav Sterba
Publikováno v:
npj Precision Oncology, Vol 8, Iss 1, Pp 1-9 (2024)
Abstract Constitutional mismatch repair deficiency (CMMRD) is a rare syndrome characterized by an increased incidence of cancer. It is caused by biallelic germline mutations in one of the four mismatch repair genes (MMR) genes: MLH1, MSH2, MSH6, or P
Externí odkaz:
https://doaj.org/article/b0a2950947714c9188792348f38d31f7
Autor:
Hana Wiedermannova, #, Peter Mudry, Jan Pavlicek, Hana Tomaskova, Andrea Hladikova, Hana Palova, Petra Vesela, Ondrej Slaby, Jaroslav Sterba
Publikováno v:
Biomedical Papers, Vol 167, Iss 3, Pp 246-253 (2023)
Objectives. The objective of this study was to determine the incidence of neoplastic diseases and associated risk factors in the early stages of life. Methods. Data were retrospectively assessed in 730,000 live births between 2000 and 2019. The occur
Externí odkaz:
https://doaj.org/article/f49145cd8664438ab97240755e0b3ebc
Autor:
Martin Sterba, Petra Pokorna, Renata Faberova, Blanka Pinkova, Jarmila Skotakova, Anna Seehofnerova, Jan Blatny, Lucia Janigova, Olga Koskova, Hana Palova, Michal Mahdal, Lukas Pazourek, Petr Jabandziev, Ondrej Slaby, Peter Mudry, Jaroslav Sterba
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract This was a prospective cohort study of eighteen patients with large and debilitating vascular malformations with one or more major systemic complications. In all patients, we discovered activating alterations in either TEK or PIK3CA. Based o
Externí odkaz:
https://doaj.org/article/a577de5101bc4a5b9cfe353e1382fac2
Autor:
Peter Múdry, Michal Kýr, Ondřej Rohleder, Michal Mahdal, Iva Staniczková Zambo, Marta Ježová, Tomáš Tomáš, Jaroslav Štěrba
Publikováno v:
Journal of Bone Oncology, Vol 28, Iss , Pp 100362- (2021)
Purpose: Conventional osteosarcoma is an orphan disease. Current treatment approaches include combining a three drug chemotherapy schedule and surgery. The 3- and 5-year event-free survival (EFS) in localized disease is roughly 65 and 60%, respective
Externí odkaz:
https://doaj.org/article/d2c6f7ddce29434c93d6a72a9563cdf9
Autor:
Kristyna Polaskova, Tomas Merta, Alexandra Martincekova, Danica Zapletalova, Michal Kyr, Pavel Mazanek, Zdenka Krenova, Peter Mudry, Marta Jezova, Jiri Tuma, Jarmila Skotakova, Ivana Cervinkova, Dalibor Valik, Lenka Zdrazilova-Dubska, Hana Noskova, Karol Pal, Ondrej Slaby, Pavel Fabian, Sarka Kozakova, Jakub Neradil, Renata Veselska, Veronika Kanderova, Ondrej Hrusak, Tomas Freiberger, Giannoula Lakka Klement, Jaroslav Sterba
Publikováno v:
Frontiers in Oncology, Vol 9 (2020)
In order to identify reasons for treatment failures when using targeted therapies, we have analyzed the comprehensive molecular profiles of three relapsed, poor-prognosis Burkitt lymphoma cases. All three cases had resembling clinical presentation an
Externí odkaz:
https://doaj.org/article/5c281799cb3e41e29ab698bc35a5380e
Autor:
Lenka Fedorova, Peter Mudry, Katerina Pilatova, Iveta Selingerova, Jana Merhautova, Zdenek Rehak, Dalibor Valik, Eva Hlavackova, Dasa Cerna, Lucie Faberova, Pavel Mazanek, Zdenek Pavelka, Regina Demlova, Jaroslav Sterba, Lenka Zdrazilova-Dubska
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Monocyte-derived dendritic cell (DC)-based vaccines loaded with tumor self-antigens represent a novel approach in anticancer therapy. We evaluated DC-based anticancer immunotherapy (ITx) in an academic Phase I/II clinical trial for children, adolesce
Externí odkaz:
https://doaj.org/article/c3ae2baabd0d44bdbcc5b4dc91aed1c5
Autor:
Marek Handl, Marketa Hermanova, Sylva Hotarkova, Jiri Jarkovsky, Peter Mudry, Tetiana Shatokhina, Marcela Vesela, Jaroslav Sterba, Iva Zambo
Publikováno v:
Biomedical Papers, Vol 162, Iss 1, Pp 54-60 (2018)
Aims: Tumor-associated macrophages (TAMs) are known markers playing complex roles in tumorigenesis. However, the function of TAMs in a variety of malignancies is not yet fully understood. The aim of this pilot study was to quantify the density of TAM
Externí odkaz:
https://doaj.org/article/1c6457c76d7e4083896f47a80a96f470
Autor:
Eva Hlavackova, Katerina Pilatova, Dasa Cerna, Iveta Selingerova, Peter Mudry, Pavel Mazanek, Lenka Fedorova, Jana Merhautova, Lucie Jureckova, Lukas Semerad, Rita Pacasova, Lucie Flajsarova, Lenka Souckova, Regina Demlova, Jaroslav Sterba, Dalibor Valik, Lenka Zdrazilova-Dubska
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Despite efforts to develop novel treatment strategies, refractory and relapsing sarcoma, and high-risk neuroblastoma continue to have poor prognoses and limited overall survival. Monocyte-derived dendritic cell (DC)-based anti-cancer immunotherapy re
Externí odkaz:
https://doaj.org/article/b8aa3e5810634c64ad140ad8ad5c431a
Autor:
Jiri Sana, Iva Zambo, Jan Skoda, Jakub Neradil, Petr Chlapek, Marketa Hermanova, Peter Mudry, Alzbeta Vasikova, Karel Zitterbart, Ales Hampl, Jaroslav Sterba, Renata Veselska
Publikováno v:
Analytical Cellular Pathology, Vol 34, Iss 6, Pp 303-318 (2011)
Background: Co-expression of CD133, cell surface glycoprotein, and nestin, an intermediate filament protein, was determined to be a marker of neural stem cells and of cancer stem cells in neurogenic tumors. Methods: We examined the expression of CD13
Externí odkaz:
https://doaj.org/article/e23d8c57771746ad824c0d263d71901a
Autor:
Martin Sramek, Jakub Neradil, Petra Macigova, Peter Mudry, Kristyna Polaskova, Ondrej Slaby, Hana Noskova, Jaroslav Sterba, Renata Veselska
Publikováno v:
International Journal of Molecular Sciences, Vol 19, Iss 9, p 2599 (2018)
Infantile myofibromatosis represents one of the most common proliferative fibrous tumors of infancy and childhood. More effective treatment is needed for drug-resistant patients, and targeted therapy using specific protein kinase inhibitors could be
Externí odkaz:
https://doaj.org/article/45d204f60b184eaf803a86029e6f643d